Cargando…
Add-On Effect of Selenium and Vitamin D Combined Supplementation in Early Control of Graves’ Disease Hyperthyroidism During Methimazole Treatment
Prompt and stable control of hyperthyroidism is fundamental to avoid the detrimental effects of thyroid hormone excess, and antithyroid drugs, mainly methimazole (MMI), represent the first-line treatment for Graves’ disease (GD) hyperthyroidism. Decreased serum concentrations of selenium (Se) and ca...
Autores principales: | Gallo, Daniela, Mortara, Lorenzo, Veronesi, Giovanni, Cattaneo, Simona AM, Genoni, Angelo, Gallazzi, Matteo, Peruzzo, Carlo, Lasalvia, Paolo, Moretto, Paola, Bruno, Antonino, Passi, Alberto, Pini, Andrea, Nauti, Andrea, Lavizzari, Maria Antonietta, Marinò, Michele, Lanzolla, Giulia, Tanda, Maria Laura, Bartalena, Luigi, Piantanida, Eliana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240752/ https://www.ncbi.nlm.nih.gov/pubmed/35784564 http://dx.doi.org/10.3389/fendo.2022.886451 |
Ejemplares similares
-
Immunomodulatory role of vitamin D and selenium supplementation in newly diagnosed Graves’ disease patients during methimazole treatment
por: Gallo, Daniela, et al.
Publicado: (2023) -
Immunological Drivers in Graves' Disease: NK Cells as a Master Switcher
por: Gallo, Daniela, et al.
Publicado: (2020) -
Management of Graves’ hyperthyroidism and orbitopathy in time of COVID-19 pandemic
por: Bartalena, L., et al.
Publicado: (2020) -
Regulatory T Cells in the Pathogenesis of Graves’ Disease
por: Kustrimovic, Natasa, et al.
Publicado: (2023) -
Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease
por: Lanzolla, Giulia, et al.
Publicado: (2021)